Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients
Open Access
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 179 (2) , 361-367
- https://doi.org/10.1016/j.atherosclerosis.2004.10.021
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Efficacy and Safety of Ezetimibe Coadministered With Simvastatin in Patients With Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled TrialMayo Clinic Proceedings, 2004
- Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic MiceCirculation, 2003
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- Coming of Age of C-Reactive ProteinCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in HumansCirculation, 2002
- Simvastatin Lowers C-Reactive Protein Within 14 DaysCirculation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1998